An open-label, multicenter; Post-Marketing Requirement (PMR) study to investigate the safety, tolerability and efficacy of octaplas in the management of pediatric patients who require replacement of multiple coagulation factors.
|Effective start/end date||2/1/16 → 1/31/18|
- OCTAPHARMA USA, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.